Cardiology

The CGTLive™ Cardiology specialty topic page contains video interviews with key opinion leaders in the field of cardiology and up-to-date clinical news coverage on the latest cardiology gene and cell therapies for heart disease. It houses information on relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for heart conditions.

Latest News

Data Roundup: June 2025 Features Updates from EHA, ASCO, and More
Data Roundup: June 2025 Features Updates from EHA, ASCO, and More

July 1st 2025

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

Around the Helix: Cell and Gene Therapy Company Updates – June 25, 2025
Around the Helix: Cell and Gene Therapy Company Updates – June 25, 2025

June 25th 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 18, 2025
Around the Helix: Cell and Gene Therapy Company Updates – June 18, 2025

June 18th 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025
Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025

June 11th 2025

Nuevocor Snags IND Clearance for Gene Therapy Trial in LMNA DCM
Nuevocor Snags IND Clearance for Gene Therapy Trial in LMNA DCM

June 11th 2025

More News

Around the Helix: Cell and Gene Therapy Company Updates – March 6, 2024

Around the Helix: Cell and Gene Therapy Company Updates – March 6, 2024

Noah Stansfield
March 6th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 28, 2024

Around the Helix: Cell and Gene Therapy Company Updates – February 28, 2024

Noah Stansfield
February 28th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 21, 2024

Around the Helix: Cell and Gene Therapy Company Updates – February 21, 2024

Noah Stansfield;Victoria Johnson
February 21st 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Roger Hajjar, MD, cofounder of Medera and Sardocor and the director of the Mass General Brigham Gene and Cell Therapy Institute

Sardocor’s Heart Failure Gene Therapy SRD-001 Garners Fast Track Designation as First Patients Are Dosed

Noah Stansfield
February 15th 2024

The first 3 participants in the MUSIC-HFpEF trial have now been dosed with the AAV vector-based gene therapy.

Around the Helix: Cell and Gene Therapy Company Updates – February 14, 2024

Around the Helix: Cell and Gene Therapy Company Updates – February 14, 2024

Noah Stansfield
February 14th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 7, 2024

Around the Helix: Cell and Gene Therapy Company Updates – February 7, 2024

Noah Stansfield
February 7th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – January 31, 2024

Around the Helix: Cell and Gene Therapy Company Updates – January 31, 2024

Noah Stansfield
January 31st 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – January 24, 2024

Around the Helix: Cell and Gene Therapy Company Updates – January 24, 2024

Noah Stansfield
January 24th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – January 17, 2024

Around the Helix: Cell and Gene Therapy Company Updates – January 17, 2024

Noah Stansfield
January 17th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

MultiStem Cell Therapy Not Superior to Placebo in Patients With Ischemic Stroke

MultiStem Cell Therapy Not Superior to Placebo in Patients With Ischemic Stroke

Victoria Johnson
January 16th 2024

Further research is needed to determine if cell therapy may be beneficial to certain subgroups of patients.

Around the Helix: Cell and Gene Therapy Company Updates – January 10, 2024

Around the Helix: Cell and Gene Therapy Company Updates – January 10, 2024

Noah Stansfield
January 10th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

After Exa-Cel: Exploring the Next Wave of CRISPR Gene Editing Strategies

After Exa-Cel: Exploring the Next Wave of CRISPR Gene Editing Strategies

Victoria Johnson
January 3rd 2024

The approval of exa-cel, the first gene editing therapy, may herald a new era in developing gene editing strategies.

Around the Helix: Cell and Gene Therapy Company Updates – January 3, 2024

Around the Helix: Cell and Gene Therapy Company Updates – January 3, 2024

Noah Stansfield
January 3rd 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive's Clinical Trials to Watch in 2024

CGTLive's Clinical Trials to Watch in 2024

Matt Hoffman
January 1st 2024

These, among many others, are some of the key clinical trials of gene, cell, and regenerative therapies that the CGTLive staff will be following throughout 2024.

CGTLive's Pillars of Progress 2023: Top FDA Approval News in Cell and Gene Therapy

CGTLive's Pillars of Progress 2023: Top FDA Approval News in Cell and Gene Therapy

CGTLive Staff
December 31st 2023

Take a look at the stories that stood out as pillars of progress and success in endocrinology gene and cell therapy development in 2023.

Around the Helix: Cell and Gene Therapy Company Updates – December 27, 2023

Around the Helix: Cell and Gene Therapy Company Updates – December 27, 2023

Noah Stansfield
December 27th 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive's Pillars of Progress 2023: Top News in Cardiology

CGTLive's Pillars of Progress 2023: Top News in Cardiology

CGTLive Staff
December 27th 2023

Take a look at the stories that stood out as pillars of progress and success in cardiology gene and cell therapy development in 2023.

Around the Helix: Cell and Gene Therapy Company Updates – December 20, 2023

Around the Helix: Cell and Gene Therapy Company Updates – December 20, 2023

Noah Stansfield
December 20th 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – December 13, 2023

Around the Helix: Cell and Gene Therapy Company Updates – December 13, 2023

Noah Stansfield
December 13th 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – December 1, 2023

CGTLive’s Weekly Rewind – December 8, 2023

CGTLive Staff
December 8th 2023

Review top news and interview highlights from the week ending December 8, 2023.

Around the Helix: Cell and Gene Therapy Company Updates – December 6, 2023

Around the Helix: Cell and Gene Therapy Company Updates – December 6, 2023

Noah Stansfield
December 6th 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – December 1, 2023

CGTLive’s Weekly Rewind – December 1, 2023

CGTLive Staff
December 1st 2023

Review top news and interview highlights from the week ending December 1, 2023.

Around the Helix: Cell and Gene Therapy Company Updates – November 29, 2023

Around the Helix: Cell and Gene Therapy Company Updates – November 29, 2023

Noah Stansfield
November 29th 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Eileen Tzng, BA, on Exploring Exosome and RNA-based Treatment Methods for Heart Failure

Eileen Tzng, BA, on Exploring Exosome and RNA-based Treatment Methods for Heart Failure

Eileen Tzng, BA
November 29th 2023

The life science research professional at Stanford University discussed preclinical research she presented at the American Heart Association’s Scientific Sessions 2023.

Nexcella’s Light Chain Amyloidosis CAR-T NXC-201 Expands Clinical Trial Activities Into the US

Nexcella’s Light Chain Amyloidosis CAR-T NXC-201 Expands Clinical Trial Activities Into the US

Noah Stansfield
November 28th 2023

The CAR-T was already being assessed in the ongoing phase 1a/1b NEXICART-1 clinical trial in Israel ahead of this IND clearance by the FDA.

Novel Vector Development is Essential as Gene Therapy Emerges as a New Therapeutic Modality in Cardiology

Novel Vector Development is Essential as Gene Therapy Emerges as a New Therapeutic Modality in Cardiology

Noah Stansfield
November 26th 2023

Roger Hajjar, MD, the director of the Mass General Brigham Gene and Cell Therapy Institute, spoke about his presentation on gene therapy for cardiologists at AHA’s 2023 Scientific Sessions.

Fernanda Mesquita, PhD, on Using LAMA2-Exosomes to Improve Cardiomyocyte Survival in Stroke

Fernanda Mesquita, PhD, on Using LAMA2-Exosomes to Improve Cardiomyocyte Survival in Stroke

Fernanda Mesquita, PhD
November 26th 2023

The research associate at the The Texas Heart Institute discussed preclinical research she presented at AHA’s 2023 Scientific Sessions on MSC-derived exosomes.

Xaviar Michael Jones, MD, on Expanding Horizons in RNA Therapeutics Through Collaboration

Xaviar Michael Jones, MD, on Expanding Horizons in RNA Therapeutics Through Collaboration

Xaviar Michael Jones, MD
November 21st 2023

The postdoctoral research fellow at Cedars Sinai Medical Center discussed the future of RNA therapy in the context of research in systemic sclerosis he presented at AHA’s Scientific Sessions 2023.

Steve Nissen, MD, chief academic officer of the Heart Vascular & Thoracic Institute at Cleveland Clinic

Lepodisiran Reduces Lipoprotein(a) Levels Safely in Phase 1 Data, Paving Way for Further Study

Matt Hoffman
November 19th 2023

Eli Lilly’s small interfering RNA therapy showed significant serum reductions with a single dose while remaining well-tolerated. A larger phase 2 study is currently ongoing.

Patients With Congestive Heart Failure Show Clinically Meaningful Improvements After Gene Therapy

Patients With Congestive Heart Failure Show Clinically Meaningful Improvements After Gene Therapy

Victoria Johnson
November 18th 2023

AskBio presented data from a phase 1/2 trial of AB-1002 gene therapy at the AHA Scientific Sessions 2023 meeting.

<1234567>
© 2025 MJH Life Sciences

All rights reserved.